Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Background: Advanced sarcoma is a group of heterogeneous disease with poor prognosis and poor efficacy of medical treatment. They represent a promising group of tumors to assess molecular-based therapy (MBT) strategy. Patients and methods: Genomic profiles of patients with advanced sarcoma included...

Full description

Bibliographic Details
Main Authors: Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Translational Oncology
Subjects:
Molecular profiling
Sarcoma
Precision medicine
Molecular-targeted therapy
Advanced cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320303624

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320303624

Similar Items